BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26498944)

  • 1. Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium.
    Lousada I; Comenzo RL; Landau H; Guthrie S; Merlini G
    Adv Ther; 2015 Oct; 32(10):920-8. PubMed ID: 26498944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single German centre experience with patient journey and care-relevant needs in amyloidosis: The German AMY-NEEDS research and care program.
    Ihne-Schubert SM; Leberzammer M; Weidgans M; Frantz S; Einsele H; Knop S; Schubert T; Bratan T; Störk S; Neuderth S
    PLoS One; 2024; 19(5):e0297182. PubMed ID: 38768126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability for Kidney Transplantation in AL Amyloidosis: A Survey Study of Transplant and Amyloidosis Physicians.
    Lam R; Lim MA; Dember LM
    Kidney360; 2021 Dec; 2(12):1987-1997. PubMed ID: 35419526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
    Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
    J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time.
    Sanchorawala V; McCausland KL; White MK; Bayliss MS; Guthrie SD; Lo S; Skinner M
    Br J Haematol; 2017 Nov; 179(3):461-470. PubMed ID: 28850697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation.
    Raschle J; Banz Y; Suter T; Pabst T
    Swiss Med Wkly; 2014 Feb; 144():w13922. PubMed ID: 24554372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma.
    Madan S; Dispenzieri A; Lacy MQ; Buadi F; Hayman SR; Zeldenrust SR; Rajkumar SV; Gertz MA; Kumar SK
    Mayo Clin Proc; 2010 Mar; 85(3):232-8. PubMed ID: 20194151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients
    Shu J; Lo S; Phillips M; Sun F; Seldin DC; Berenbaum I; Berk JL; Sanchorawala V
    Amyloid; 2016 Sep; 23(3):188-193. PubMed ID: 27460276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of immunoglobulin light chain (primary or AL) amyloidosis.
    Gertz MA; Buadi FK; Hayman SR
    Oncology (Williston Park); 2011 Jun; 25(7):620-6. PubMed ID: 21888261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I Approach Light Chain Amyloidosis.
    Chowdhury RB; Leung N
    G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of parent and carer experiences and expectations of paediatric rheumatology care in New South Wales.
    Coda A; Jones J; Grech D; Grewal DS
    Aust Health Rev; 2017 Aug; 41(4):372-377. PubMed ID: 27467400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea.
    Kim SJ; Lee GY; Jang HR; Choi JO; Kim JS; Kim HJ; Lee SY; Min JH; Jeon ES; Kim K
    Amyloid; 2013 Dec; 20(4):204-11. PubMed ID: 23914780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.
    Skinner M; Sanchorawala V; Seldin DC; Dember LM; Falk RH; Berk JL; Anderson JJ; O'Hara C; Finn KT; Libbey CA; Wiesman J; Quillen K; Swan N; Wright DG
    Ann Intern Med; 2004 Jan; 140(2):85-93. PubMed ID: 14734330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.
    Hazenberg BP; Croockewit A; van der Holt B; Zweegman S; Bos GM; Delforge M; Raymakers RA; Sonneveld P; Vellenga E; Wijermans PW; von dem Borne PA; van Oers MH; de Weerdt O; Spoelstra FM; Lokhorst HM;
    Haematologica; 2015 May; 100(5):677-82. PubMed ID: 25661441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis.
    Sachchithanantham S; Roussel M; Palladini G; Klersy C; Mahmood S; Venner CP; Gibbs S; Gillmore J; Lachmann H; Hawkins PN; Jaccard A; Merlini G; Wechalekar AD
    J Clin Oncol; 2016 Jun; 34(17):2037-45. PubMed ID: 27114592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous peripheral blood hematopoietic stem cell transplantation for patients with primary light chain amyloidosis: experience of 31 cases in a single center].
    Li J; Feng J; Cao XX; Zhang CL; Shen KN; Huang XF; Zhang CL; Duan MH; Zhang W; Zhu TN; Cai HC; Zhang L; Cai H; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):201-4. PubMed ID: 27033756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
    Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
    Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients].
    Adam Z; Ozábalová E; Němec P; Bedáňová H; Kuman M; Krejčí J; Špinarová L; Žampachová V; Čermáková Z; Pour L; Krejčí M; Sanecká V; Štork M; Pika T; Straub J; Adamová D; Stavařová Y; Král Z; Mayer J
    Vnitr Lek; 2018; 64(4):441-449. PubMed ID: 29791180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.